US StockDetailed Quotes

Provided by Tiger Trade Technology Pte. Ltd.

F/m Emerald Life Sciences Innovation ETF

48.06

+0.57331.21%

Post-market: 48.060.00000.00%19:30 EDT

Volume:5K

Turnover:221.35K

Market Cap:132.51M

PE:- -

High:48.19

Open:48.00

Low:47.87

Close:47.49

52wk High:48.78

52wk Low:27.34

Shares:2.76M

Float Shares:2.76M

Volume Ratio:1.31

T/O Rate:0.17%

Dividend:- -

Dividend Rate:- -

ROE:--

ROA:--

PB:--

PE(LYR):- -

Loading ...

Overview Company News Filings

Concept

no data

No relevant data is available

Capital Flow

Inflow:

Outflow:

News

Stocks to Watch: Intuit, Spyre Therapeutics, Zoom Communications, nCino

Spyre Therapeutics Stock (SYRE) Tumbles 14% in After-Hours – Here’s What Spooked Investors

Spyre Therapeutics Won't Prioritize Rheumatoid Arthritis Monotherapy After Trial

Spyre Therapeutics announces results from RA sub-study of SKYWAY basket trial

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.etasphere.com/stock/LFSC"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"LFSC","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LFSC\",,,,,undefined,":{"symbol":"LFSC","market":"US","secType":"STK","nameCN":"F/m Emerald Life Sciences Innovation ETF","latestPrice":48.0628,"timestamp":1787688000000,"preClose":47.4895,"halted":0,"volume":4612,"hourTrading":{"tag":"盘后","latestPrice":48.0628,"preClose":48.0628,"latestTime":"19:30 EDT","volume":119,"amount":5624.601164,"timestamp":1787700602166,"change":0,"changeRate":0,"amplitude":0.002022},"delay":0,"changeRate":0.012072142263026633,"floatShares":2757035,"shares":2757035,"eps":0,"marketStatus":"Post-Mkt","change":0.5733,"latestTime":"08-25 19:56:02 EDT","open":48,"high":48.19,"low":47.87,"amount":221346.80604,"amplitude":0.006738,"askPrice":72.16,"askSize":200,"bidPrice":47.48,"bidSize":1,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"Closed","tradingStatus":0,"beginTime":1787702400000},"marketStatusCode":4,"adr":0,"exchange":"NASDAQ","adjPreClose":47.4895,"sharesOutstanding":2657035,"nav":47.8,"aum":131786273,"bidAskSpread":0,"postHourTrading":{"tag":"盘后","latestPrice":48.0628,"preClose":48.0628,"latestTime":"19:30 EDT","volume":119,"amount":5624.601164,"timestamp":1787700602166,"change":0,"changeRate":0,"amplitude":0.002022},"volumeRatio":1.311494},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"LFSC\",,,,,undefined,":{"symbol":"LFSC","floatShares":2757035,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":1.311494,"shares":2757035,"dividePrice":0,"high":48.19,"amplitude":0.006738,"preClose":47.4895,"low":47.87,"week52Low":27.3402,"pbRate":"--","week52High":48.78,"institutionHeld":0,"latestPrice":48.0628,"committee":-0.99005,"eps":0,"divideRate":0,"volume":4612,"delay":0,"ttmEps":0,"open":48,"prevYearClose":36.6147,"prevWeekClose":47.7953,"prevMonthClose":45.55,"prevQuarterClose":45.2033,"fiveDayClose":47.489,"twentyDayClose":45.3952,"sixtyDayClose":39.3901},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/LFSC\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"LFSC\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"LFSC\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"LFSC\",pageSize:4,pageCount:1,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662768622","title":"Stocks to Watch: Intuit, Spyre Therapeutics, Zoom Communications, nCino","url":"https://stock-news.laohu8.com/highlight/detail?id=2662768622","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662768622?lang=en_us&edition=fundamental","pubTime":"2026-08-26 07:05","pubTimestamp":1787699100,"startTime":"0","endTime":"0","summary":"Intuit projected that sales growth would slow in the year ahead, weighed down by expected declines in the company's desktop business. The company may also accept short-term trade-offs in its business as it looks to boost TurboTax customers, its CFO told The Wall Street Journal. Shares fell 9.8% to $322.57 in after-hours trading on Tuesday.Spyre Therapeutics said it will not prioritize developing one of its drug candidates as a monotherapy for rheumatoid arthritis after results from a trial missed its internal targets. The stock slid 11% to $95.09 after the bell.Zoom Communications issued guidance for third-quarter adjusted earnings per share that missed Wall Street expectations. Shares were down 3.9% at $97.00.NCino projected third-quarter revenue in a range with a midpoint below analyst expectations. The stock was down 5.6% at $19.65.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0823434740.USD","LU0861579265.USD","LU1043141396.HKD","LU1803068979.SGD","LU1861558580.USD","LU1823568750.SGD","BK4613","LU0889565833.HKD","BK4548","LU0266013472.USD","LU0661504455.SGD","LU1934455863.HKD","BK4554","LU1674673428.USD","LU2065170008.USD","LU0511384066.AUD","BK4528","IE00B19Z8W00.USD","LU1674673691.USD","BK4535","BK4023","LU2089283258.USD","LFSC","LU1815333072.USD","LU1804176565.USD","NCNO","LU2065171402.SGD","LU0738911758.USD","LU1934455194.USD","LU0289961442.SGD","LU0061474960.USD","LU0965508806.USD","IE00BQXX3C00.GBP","LU1861559042.SGD","LU1037948897.HKD","BK4581","SG9999001424.SGD","BK4139","LU1366333091.USD","LU0823434583.USD","LU0097036916.USD","LU2095319765.USD","LU0640476718.USD","SG9999002232.USD","BK4567","LU0426417589.USD","BK4525","BK4534","LU1235294995.USD","LU0965509283.SGD","LU0965509010.AUD","LU2065171311.SGD","LU0011850046.USD","LU0957791311.USD","SG9999002224.SGD","SYRE","ZM","BK4505","LU1121112475.USD","LU0158827948.USD","IE00BQXX3D17.EUR","LU1043141123.HKD","LU0109392836.USD","BK4585","LU0689626769.HKD","IE0009356076.USD","INTU","LU0426412945.USD","LU0124676726.USD","LU1046421795.USD","IE00B19Z8X17.USD","LU0289739343.SGD","LU0082616367.USD","LU2063271972.USD","BK4588","LU1037948541.HKD","BK4532","LU0157215616.USD","LU1934455277.USD","LU2023251221.USD","BK4608","BK4551","LU0342679015.USD","IE00B19Z9505.USD","LU0719512351.SGD","LU1280957306.USD","LU0949170772.SGD","BK4533","LU0345774391.USD","LU1236620750.USD","LU1778281490.HKD","IE00B5949003.HKD","LU1236620834.HKD","LU2265009873.SGD","LU2089284900.SGD","LU2210150020.SGD","LU0994945656.USD","LU2065169927.USD","LU2210149790.SGD","LU0965509101.SGD","LU0345774631.USD","IE00BQXX3F31.USD","GB00BDT5M118.USD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662776851","title":"Spyre Therapeutics Stock (SYRE) Tumbles 14% in After-Hours – Here’s What Spooked Investors","url":"https://stock-news.laohu8.com/highlight/detail?id=2662776851","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662776851?lang=en_us&edition=fundamental","pubTime":"2026-08-26 06:51","pubTimestamp":1787698276,"startTime":"0","endTime":"0","summary":"Spyre Therapeutics ($SYRE) fell as much as 14% in after‑hours trading on Tuesday after the company said it will stop developing its rheumatoid arth...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/spyre-therapeutics-stock-syre-tumbles-14-in-after-hours-heres-what-spooked-investors?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/spyre-therapeutics-stock-syre-tumbles-14-in-after-hours-heres-what-spooked-investors?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["SYRE","ISBC","BK4139","BK4211","LFSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662675221","title":"Spyre Therapeutics Won't Prioritize Rheumatoid Arthritis Monotherapy After Trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2662675221","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662675221?lang=en_us&edition=fundamental","pubTime":"2026-08-26 05:00","pubTimestamp":1787691600,"startTime":"0","endTime":"0","summary":"Spyre Therapeutics will not prioritize the use of its SPY072 drug candidate as a monotherapy to treat rheumatoid arthritis, saying that results from a phase 2 trial did not meet the company's threshold.Shares of the biotechnology company fell on the news, losing 13% in after-hours trading to $93.50.A substudy of the drug to treat rheumatoid arthritis, part of a broader phase 2 study focusing on rheumatic diseases, showed that high and low doses both had statistically significant benefits over a placebo on certain endpoints, Spyre said. The low dose demonstrated a statistically significant benefit on the study's primary endpoint, the company added.But the magnitude of the results missed the company's targets, it said.\"The results provide proof-of-mechanism for TL1A in RA and support its potential in other autoimmune diseases and as a combination component, but did not meet the Company's internal bar to prioritize advancement of SPY072 in RA,\" the company said. SPY072 is designed to inhi","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4539","SYRE","BK4007","BK4139","LENZ","LFSC"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662754700","title":"Spyre Therapeutics announces results from RA sub-study of SKYWAY basket trial","url":"https://stock-news.laohu8.com/highlight/detail?id=2662754700","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662754700?lang=en_us&edition=fundamental","pubTime":"2026-08-26 04:05","pubTimestamp":1787688312,"startTime":"0","endTime":"0","summary":"Spyre Therapeutics (SYRE) announced results from the RA sub-study of its Phase 2 SKYWAY basket trial evaluating SPY072 in rheumatic diseases. Both ...","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/spyre-therapeutics-announces-results-from-ra-sub-study-of-skyway-basket-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/spyre-therapeutics-announces-results-from-ra-sub-study-of-skyway-basket-trial-thefly-news?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4139","RA","SYRE","LENZ","LFSC","BK4539","BK4007"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":4,"totalPage":50,"pageCount":1,"totalSize":198,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/market/plate/belongs/LFSC\",params:#limit:6,delay:false,,,undefined,":[]}}